Advisor Group Holdings, Inc. Puma Biotechnology, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 17,494 shares of PBYI stock, worth $59,129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,494
Previous 1,143
1430.53%
Holding current value
$59,129
Previous $3,000
1600.0%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding PBYI
# of Institutions
116Shares Held
30.9MCall Options Held
32.7KPut Options Held
200-
Acorn Capital Advisors, LLC New York, NY3.94MShares$13.3 Million8.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$12.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$12.1 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.01MShares$6.79 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.83MShares$6.18 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $154M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...